MERCK KGAA NAM.SP.ADR (MRKC) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.045x

Based on the latest financial reports, MERCK KGAA NAM.SP.ADR (MRKC) has a cash flow conversion efficiency ratio of 0.045x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€1.29 Billion ≈ $1.51 Billion USD) by net assets (€28.66 Billion ≈ $33.51 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See MERCK KGAA NAM.SP.ADR balance sheet independence to measure how much of total assets are equity-financed.

MERCK KGAA NAM.SP.ADR - Cash Flow Conversion Efficiency Trend (2020–2025)

This chart illustrates how MERCK KGAA NAM.SP.ADR's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check MERCK KGAA NAM.SP.ADR (MRKC) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.

MERCK KGAA NAM.SP.ADR Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of MERCK KGAA NAM.SP.ADR ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Lenovo Group Limited
F:LHL1
0.073x
Samvardhana Motherson International Limited
NSE:MOTHERSON
0.078x
Hengtong Optic Electric Co Ltd
SHG:600487
0.014x
Api Group Corp
NYSE:APG
0.024x
Banco Santander Chile
SN:BSANTANDER
-0.075x
Samsung Fire & Marine Insurance
KO:000810
0.080x
Super Micro Computer Inc
NASDAQ:SMCI
-0.873x
Lattice Semiconductor Corporation
NASDAQ:LSCC
0.068x

Annual Cash Flow Conversion Efficiency for MERCK KGAA NAM.SP.ADR (2020–2025)

The table below shows the annual cash flow conversion efficiency of MERCK KGAA NAM.SP.ADR from 2020 to 2025. For the full company profile with market capitalisation and key ratios, see MERCK KGAA NAM.SP.ADR market cap and net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 €28.66 Billion
≈ $33.51 Billion
€3.93 Billion
≈ $4.60 Billion
0.137x -10.29%
2024-12-31 €29.99 Billion
≈ $35.06 Billion
€4.59 Billion
≈ $5.36 Billion
0.153x +8.13%
2023-12-31 €26.75 Billion
≈ $31.28 Billion
€3.78 Billion
≈ $4.42 Billion
0.141x -13.64%
2022-12-31 €26.00 Billion
≈ $30.40 Billion
€4.26 Billion
≈ $4.98 Billion
0.164x -24.02%
2021-12-31 €21.42 Billion
≈ $25.04 Billion
€4.62 Billion
≈ $5.40 Billion
0.216x +5.49%
2020-12-31 €17.02 Billion
≈ $19.89 Billion
€3.48 Billion
≈ $4.06 Billion
0.204x --

About MERCK KGAA NAM.SP.ADR

F:MRKC Germany Drug Manufacturers - Specialty & Generic
Market Cap
$17.07 Billion
€14.60 Billion EUR
Market Cap Rank
#1457 Global
#326 in Germany
Share Price
€22.60
Change (1 day)
-2.59%
52-Week Range
€20.20 - €26.20
All Time High
€44.30
About

Merck KGaA operates as a science and technology company in Germany and internationally. It operates through Life Science, Healthcare, and Electronics segments. The Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as the industrial sector. This segment offers science and lab solutions comprising reagents, consumables,… Read more